- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 3.1M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 2.39M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 1.45M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$3.14M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$4.37M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $3.21M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $5.48M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $5.3M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $9.57M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $16.54M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $22.88M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $3.87M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $2.43M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $3.88M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.46M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $4.86M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $7.59M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $9.19M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $12.03M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$2.40 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$4.87 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$2.40 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$4.87 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $2.44M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $3.12M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $3.56M |
| Rd Expense restated | Q1 2024 · Mar 31, 2023 | $4.02M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$5.74M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$7.05M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$5.79M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$7.09M |
| Revenue | Q1 2024 · Mar 31, 2024 | $203.27K |
| Revenue | Q1 2024 · Mar 31, 2023 | $51.43K |